Evaheart develops the EVAHEART®2 Left Ventricular Assist Device, an implantable centrifugal pump that utilizes a hydraulically levitated impeller to ensure gentle blood circulation and maintain native pulsatility in patients with advanced heart failure. The device addresses the critical need for effective short- and long-term support in heart failure management, minimizing risks such as clot formation and post-operative complications.
Funding
Funding not disclosed
Founders
Product
Problem
Patients with advanced heart failure often require mechanical circulatory support, but existing left ventricular assist devices (LVADs) can cause complications such as blood clot formation and damage to blood cells due to non-physiological blood flow. These complications can limit the effectiveness and long-term viability of LVAD therapy.
Solution
Evaheart has developed the EVAHEART®2 LVAD, an implantable centrifugal pump designed to provide both short-term and long-term support for patients with advanced heart failure while minimizing common complications. The EVAHEART®2 utilizes a proprietary hydraulically levitated impeller within its centrifugal pump to ensure gentle blood circulation and maintain native pulsatility. The device's open-vane impeller design promotes excellent blood washout and allows operation at low speeds, reducing shear stress on blood cells. A novel double-cuff tipless inflow cannula is designed for improved anatomical fitting, enhancing tissue in-growth and potentially decreasing the risk of post-LVAD stroke.
Target Audience
The primary target audience includes cardiac surgeons, heart failure specialists, and hospitals specializing in advanced heart failure therapies and mechanical circulatory support.
Features
- Hydraulically levitated impeller using a thin layer of circulating sterile water to lubricate the mechanical seal and cool the shaft, minimizing clot formation risk.
- Open-vane impeller with large flow gaps for effective blood washout and low-speed operation to reduce shear stress.
- Pump speed modulation allowing customizable speed reduction to facilitate aortic valve opening.
- Double-cuff tipless inflow cannula designed for improved anatomical fitting and enhanced tissue in-growth.
- Low-profile cannula design with flush inflow ostium and rotational apex suture cuff.